The complex regulation of TGF-β in cardiovascular disease

References

• GasparyanAYAyvazyanLBlackmoreHKitasGDWriting a narrative biomedical review: considerations for authors, peer reviewers, and editorsRheumatol Int201131111409141721800117
   PubMed Web of Science ®Google Scholar
• RedondoSSantos-GallegoCGTejerinaTTGF-beta1: a novel target for cardiovascular pharmacologyCytokine Growth Factor Rev2007183–427928617485238
   PubMed Web of Science ®Google Scholar
• LebrinFGoumansMJJonkerLEndoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transductionEMBO J200423204018402815385967
   PubMed Web of Science ®Google Scholar
• LoureiroJSchilteMAguileraABMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposureNephrol Dial Transplant20102541098110820067910
   PubMed Web of Science ®Google Scholar
• RedondoSRuizESantos-GallegoCGPadillaETejerinaTPioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-gamma, transforming growth factor-beta1, and a Smad2-dependent mechanismDiabetes200554381181715734860
   PubMed Web of Science ®Google Scholar
• TangYYangXFrieselREVaryCPLiawLMechanisms of TGF-β-induced differentiation in human vascular smooth muscle cellsJ Vasc Res201148648549421832838
   PubMed Web of Science ®Google Scholar
• AzumaMMotegiKAotaKYamashitaTYoshidaHSatoMTGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1Exp Cell Res1999250121322210388535
   PubMed Web of Science ®Google Scholar
• GoumansMJValdimarsdottirGItohSActivin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signalingMol Cell200312481782814580334
   PubMed Web of Science ®Google Scholar
• TojoMTakebeATakahashiSSmad7-deficient mice show growth retardation with reduced viabilityJ Biochem2012151662163122383537
   PubMed Web of Science ®Google Scholar
• LebrinFDeckersMBertolinoPTen DijkePTGF-beta receptor function in the endotheliumCardiovasc Res200565359960815664386
   PubMed Web of Science ®Google Scholar
• McAllisterKAGroggKMJohnsonDWEndoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1Nat Genet1994843453517894484
   PubMed Web of Science ®Google Scholar
• BergJNGallioneCJStenzelTTThe activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2Am J Hum Genet199761160679245985
   PubMed Web of Science ®Google Scholar
• MoustakasAHeldinCHNon-Smad TGF-beta signalsJ Cell Sci2005118Pt 163573358416105881
   PubMed Web of Science ®Google Scholar
• YangFChungACHuangXRLanHYAngiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3Hypertension200954487788419667256
   PubMed Web of Science ®Google Scholar
• TsaparaALuthertPGreenwoodJHillCSMatterKBaldaMSThe RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migrationMol Biol Cell201021686087020089843
   PubMed Web of Science ®Google Scholar
• HongMWilkesMCPenheiterSGGuptaSKEdensMLeofEBNon-Smad transforming growth factor-β signaling regulated by focal adhesion kinase binding the p85 subunit of phosphatidylinositol 3-kinaseJ Biol Chem201128620178411785021454615
   PubMed Web of Science ®Google Scholar
• LiuQZhangYMaoHA crosstalk between the Smad and JNK signaling in the TGF-β-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cellsPLoS One201272e3200922384127
   PubMed Web of Science ®Google Scholar
• StrippoliRBenedictoIPérez LozanoMLCerezoALópez-CabreraMdel PozoMAEpithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathwayDis Model Mech200814–526427419093035
   PubMed Web of Science ®Google Scholar
• StrippoliRBenedictoIForondaMp38 maintains E-cadherin expression by modulating TAK1-NF-kappa B during epithelial-to-mesenchymal transitionJ Cell Sci2010123Pt 244321433121098640
   PubMed Web of Science ®Google Scholar
• GhoshAKBhattacharyyaSWeiJPeroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivatorFASEB J20092392968297719395477
   PubMed Web of Science ®Google Scholar
• ChenYGEndocytic regulation of TGF-beta signalingCell Res2009191587019050695
   PubMed Web of Science ®Google Scholar
• HayesSChawlaACorveraSTGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2J Cell Biol200215871239124912356868
   PubMed Web of Science ®Google Scholar
• RazaniBZhangXLBitzerMvon GersdorffGBöttingerEPLisantiMPCaveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptorJ Biol Chem200127696727673811102446
   PubMed Web of Science ®Google Scholar
• ChenCLLiuIHFlieslerSJHanXHuangSSHuangJSCholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesisJ Cell Sci2007120Pt 203509352117878231
   PubMed Web of Science ®Google Scholar
• ZhaoBWangQDuJLuoSXiaJChenYGPICK1 promotes caveolin-dependent degradation of TGF-β type I receptorCell Res2012
   Web of Science ®Google Scholar
• IkushimaHMiyazonoKCellular context-dependent “colors” of transforming growth factor-beta signalingCancer Sci2010101230631220067465
   PubMed Web of Science ®Google Scholar
• GregoryPABertAGPatersonELThe miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1Nat Cell Biol200810559360118376396
   PubMed Web of Science ®Google Scholar
• PetroccaFVisoneROnelliMRE2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancerCancer Cell200813327228618328430
   PubMed Web of Science ®Google Scholar
• VenturaAYoungAGWinslowMMTargeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clustersCell2008132587588618329372
   PubMed Web of Science ®Google Scholar
• KumarswamyRVolkmannIJazbutyteVDangwalSParkDHThumTTransforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21Arterioscler Thromb Vasc Biol201232236136922095988
   PubMed Web of Science ®Google Scholar
• HataADavisBNControl of microRNA biogenesis by TGFbeta signaling pathway-A novel role of Smads in the nucleusCytokine Growth Factor Rev2009205–651752119892582
   PubMed Web of Science ®Google Scholar
• BatutJHowellMHillCSKinesin-mediated transport of Smad2 is required for signaling in response to TGFbeta ligandsDev Cell200712226127417276343
   PubMed Web of Science ®Google Scholar
• JinQDingWMulderKMRequirement for the dynein light chain km23-21 in a Smad2-dependent transforming growth factor-beta signaling pathwayJ Bio Chem200728226191221913217420258
   PubMed Web of Science ®Google Scholar
• KurisakiAKoseSYonedaYHeldinCHMoustakasATransforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent mannerMol Biol Cell20011241079109111294908
   PubMed Web of Science ®Google Scholar
• ChenHBRudJGLinkXuHNuclear targeting of transforming growth factor-beta-activated Smad complexesJ Biol Chem200528022213292133615799969
   PubMed Web of Science ®Google Scholar
• KnockaertMSapkotaGAlarcónCMassaquéJBrivanlouAHUnique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signalingProc Natl Acad Sci U S A200610332119401194516882717
   PubMed Web of Science ®Google Scholar
• VardouliLMoustakasAStournarasCLIM kinase and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-betaJ Biol Chem200528012114481145715647284
   PubMed Web of Science ®Google Scholar
• ClarkeDCLiuXDecoding the quantitative nature of TGF-beta/Smad signalingTrends Cell Biol200818943044218706811
   PubMed Web of Science ®Google Scholar
• LebastchiAHKhanSFQinLTransforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cellsAm J Transplant201111112332234121812925
   PubMed Web of Science ®Google Scholar
• CastanaresCRedondo-HorcajoMMagán-MarchalNten DijkePLamasSRodríguez-PascualFSignaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferationJ Cell Sci2007120Pt 71256126617376964
   PubMed Web of Science ®Google Scholar
• RedondoSSantos-GallegoCGGanadoPAcetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-betaCirculation2003107462662912566377
   PubMed Web of Science ®Google Scholar
• RuizERedondoSGordillo-MoscosoATejerinaTPioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathwayJ Pharmacol Exp Ther2007321243143817267584
   PubMed Web of Science ®Google Scholar
• JaffeMSestiCWashingtonIMTransforming growth factor-β signaling in myogenic cells regulates vascular morphogenesis, differentiation, and matrix synthesisArterioscler Thromb Vasc Biol2012321e1e1121979435
   PubMed Web of Science ®Google Scholar
• FeinbergMWWatanabeMLebedevaMATransforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3J Biol Chem200427916163881639314754879
   PubMed Web of Science ®Google Scholar
• WalsheTEDoleVSMaharajASPatternISWagnerDDD’AmorePAInhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rollingArterioscler Thromb Vasc Biol20092981185119219461051
   PubMed Web of Science ®Google Scholar
• BasoniCNoblesMGrimshawAInhibitory control of TGF-beta1 on the activation of Rap1, CD11b, and transendothelial migration of leukocytesFASEB J200519782282415746186
   PubMed Web of Science ®Google Scholar
• RedondoSHristovMGümbelDTejerinaTWeberCBiphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1Thromb Haemost200797697998717549301
   PubMed Web of Science ®Google Scholar
• VayalilPKOlmanMMurphy-UllrichJEPostlethwaitEMLiuRMGlutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogenAm J Physiol Lung Cell Mol Physiol20052896L937L94516258002
   PubMed Web of Science ®Google Scholar
• AnituaEAguirreJJAlgortaJEffectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcersJ Biomed Mater Res B Appl Biomater200884241542117595032
   PubMed Web of Science ®Google Scholar
• MeyerAWangWQuJPlatelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overloadBlood201211941064107422134166
   PubMed Web of Science ®Google Scholar
• GraingerDJMosedaleDEMetcalfeJCWeissbergPLKempPRActive and acid-activatable TGF-beta in human sera, platelets and plasmaClin Chim Acta1995235111317634487
   PubMed Web of Science ®Google Scholar
• GraingerDJTransforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesisArterioscler Thromb Vasc Biol200424339940414699019
   PubMed Web of Science ®Google Scholar
• LutgensEGijbelsMSmookMTransforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progressionArterioscler Thromb Vasc Biol200222697598212067907
   PubMed Web of Science ®Google Scholar
• DaiJMichineauSFranckGLong term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta inductionPLoS One2011612e2890322194945
   PubMed Web of Science ®Google Scholar
• JiQWGuoMZhengJSDownregulation of T helper cell type 3 in patients with acute coronary syndromeArch Med Res200940428529319608018
   PubMed Web of Science ®Google Scholar
• KoenenRRWeberCChemokines: established and novel targets in atherosclerosisEMBO Mol Med201131271372522038924
   PubMed Web of Science ®Google Scholar
• OkamotoYGotohYUemuraOTanakaSAndoTNishidaMAge-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; population study of serum TGF-beta 1 level in JapaneseDis Markers2005212717415920293
   PubMed Web of Science ®Google Scholar
• GasparyanAYStavropoulos-KalinoglouAMikhailidisDPDouglasKMKitasGDPlatelet function in rheumatoid arthritis: arthritic and cardiovascular implicationsRheumatol Int201131215316420390282
   PubMed Web of Science ®Google Scholar
• JacksonMAhmadYBruceINCoupesBBrenchleyPEActivation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosusArthritis Res Ther200683R8116646981
   PubMed Web of Science ®Google Scholar
• López-NovoaJMBernabeuCThe physiological role of endoglin in the cardiovascular systemAm J Physiol Heart Circ Physiol20102994H959H97420656886
   PubMed Web of Science ®Google Scholar
• Blázquez-MedelaAMGarcía-OrtizLGómez-MarcosMAIncreased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patientsBMC Med201088621171985
   PubMed Web of Science ®Google Scholar
• López-NovoaJMSoluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsiaNephrol Dial Transplant200722371271417210583
   PubMed Web of Science ®Google Scholar
• DeesCAkhmetshinaAZerrPPlatelet-derived serotonin links vascular disease and tissue fibrosisJ Exp Med2011208596197221518801
   PubMed Web of Science ®Google Scholar
• PalleroMATalbert RodenMChenYFStainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosisJ Vasc Res201047430932220016205
   PubMed Web of Science ®Google Scholar
• Kieć-WilkBStolarz-SkrzypekKSliwaAZdienickaAKawecka-JaszczKPeripheral blood concentrations of TGFβ1, IGF-1 and bFGF and remodelling of the left ventricle and blood vessels in hypertensive patientsKardiol Pol2010689996100220859888
   PubMed Web of Science ®Google Scholar
• LaviadesCVaroNDíezJTransforming growth factor beta in hypertensives with cardiorenal damageHypertension200036451752211040229
   PubMed Web of Science ®Google Scholar
• SakamotoYMiyazakiATamagawaHWangGPHoriuchiSSpecific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activationAtherosclerosis20051831859315907858
   PubMed Web of Science ®Google Scholar
• McCaffreyTADuBFuCThe expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalanceJ Mol Cell Cardiol19993191627164210471347
   PubMed Web of Science ®Google Scholar
• KalininaNAgrotisAAntropovaYSmad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesionsArterioscler Thromb Vasc Biol20042481391139615166010
   PubMed Web of Science ®Google Scholar
• RaoMGuoDJaberBLTighiouartHPereiraBJBalakrishnanVSfor HEMO Study GroupTransforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patientsKidney Int200466141942715200451
   PubMed Web of Science ®Google Scholar
• SieMPUitterlindenAGBosMJTGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam StudyStroke200637112667267117023672
   PubMed Web of Science ®Google Scholar
• PengZZhanLChenSXuEAssociation of transforming growth factor-β1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: a case-control studyLipids Health Dis20111010021679448
   PubMed Web of Science ®Google Scholar
• BirosENormanPEJonesGTMeta-analysis of the association between single nucleotide polymorphisms in TGF-β receptor genes and abdominal aortic aneurysmAtherosclerosis2011219121822321855067
   PubMed Web of Science ®Google Scholar
• ClarkKJCaryNRGraceAAMetcalfeJCMicrosatellite mutation of type II transforming growth factor-beta receptor is rare in atherosclerotic plaquesArterioscler Thromb Vasc Biol200121455555911304472
   PubMed Web of Science ®Google Scholar
• Alvarez-LarránAPereiraACervantesFAssessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia veraBlood201211961363136922160617
   PubMed Web of Science ®Google Scholar
• KurodaHMatsunagaTTeruiTDecrease of Smad4 gene expression in patients with essential thrombocythaemia may cause an escape from suppression of megakaryopoiesis by transforming growth factor-beta1Br J Haematol2004124221122014687032
   PubMed Web of Science ®Google Scholar
• LiJBenchAJHuntlyBJGreenARMutation and methylation analysis of the transforming growth factor beta receptor II gene in polycythaemia veraBr J Haematol2001115487288011843821
   PubMed Web of Science ®Google Scholar
• VannucchiAMManagement of myelofibrosisHematology Am Soc Hematol Educ Program2011201122223022160038
   PubMed Web of Science ®Google Scholar
• PonceCCde LourdesFChauffailleMIharaSSSilvaMRThe relationship of the active and latent forms of TGF-β1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosisMed Oncol12272011 [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• GastinneTVigantFLavenu-BombledCAdenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis developmentExp Hematol2007351647417198875
   PubMed Web of Science ®Google Scholar
• RameshwarPNarayananRQianJDennyTNColonCGasconPNF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasisJ Immunol200016542271227710925316
   PubMed Web of Science ®Google Scholar
• CampanelliRRostiVVillaniLEvaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosisCytokine201153110010620801055
   PubMed Web of Science ®Google Scholar
• SozerSWangXZhangWCirculating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disordersBlood Cells Mol Dis200841328429118715806
   PubMed Web of Science ®Google Scholar
• VerstovsekSKantarjianHMEstrovZLong-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controlsBlood2012120612011209
   Web of Science ®Google Scholar
• Wagner-BallonOPisaniDFGastinneTProteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in miceBlood2007110134535317374740
   PubMed Web of Science ®Google Scholar
• ThepotSItzyksonRSeegersVfor Groupe Francophone des Myelodysplasies (GFM)Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)Blood2010116193735374220664061
   PubMed Web of Science ®Google Scholar